COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
FDA’s Guidance for Industry (GFI) on compounding for animals using bulk drug substances will be used in FDA inspections starting on April 1, 2023. Read the top five potential impacts on compounding for animal patients.
Access scientific studies, which include images and videos, conducted by PCCA researchers that evaluated properties and performance of SuspendIt Anhydrous.
Congratulations to Brad White, RPh and Paul White, RPh for being selected as our March Profile in Personalized Medicine.
Matt Martin, PharmD, BCSCP, PCCA Director of Clinical Services, reviews USP 797revisions and impacts on compounding pharmacies in the fourth of a four-part series.
Matt Martin, PharmD, BCSCP, PCCA Director of Clinical Services, reviews USP 797 revisions and impacts on compounding pharmacies in the third of a four-part series.